Colloidal Silicon Dioxide Excipient: Uses as a Glidant and Pharmacopeia Standards

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica as a Rheology Modifier: How It Controls Viscosity and Flow
  • Keywords: polysilicon
  • Published: 2026-11-20 01:33:48
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
34. MacCuaig W.M., Samykutty A., Foote J., Luo W., Filatenkov A., Li M., Houchen C., Grizzle W.E., McNally L.R. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics. 2022;14:969. doi: 10.3390/pharmaceutics14050969. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]

What Is Mesoporous Silica? Structure, Pore Size and Applications in Drug Delivery and Catalysis

Wood Coating Matting Agent: How to Achieve a Low-Gloss, Clear Finish
Silica Nanoparticles: Synthesis, Properties, Safety and Applications
Fumed Silica Price: 2026 Price Ranges, Grade Differences and Cost Drivers
3. Farzan M., Roth R., Schoelkopf J., Huwyler J., Puchkov M. The processes behind drug loading and release in porous drug delivery systems. Eur. J. Pharm. Biopharm. 2023;189:133-151. doi: 10.1016/j.ejpb.2023.05.019. [ DOI ] [ PubMed ] [ Google Scholar ]
2500 Mesh Silica: Particle Size, Specifications and Common Applications

What Is Low Alpha Silica? Why Alpha Emission Matters in Semiconductor Packaging

What is silica (SiO₂)?

HDK N20

What is the difference between fumed silica and precipitated silica?

silica whiteness 55. Antonino R.S., Ruggiero M., Song Z., Nascimento T.L., Lima E.M., Bohr A., Knopp M.M., Löbmann K. Impact of drug loading in mesoporous silica-amorphous formulations on the physical stability of drugs with high recrystallization tendency. Int. J. Pharm. X. 2019;1:100026. doi: 10.1016/j.ijpx.2019.100026. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]

What drives silica raw material prices?

silica testing method Nanocarriers can be divided into two principal groups: organic and inorganic types. The organic group contains lipid nanocarriers, liposomes, polymeric nanoparticles, dendrimers, etc. In the case of the carriers in this group, the limited volume of delivered active pharmaceutical ingredient (API) is a clear disadvantage, along with decreased stability, and good sensitivity to temperature, pH, and enzymes in a physiological environment. The inorganic group contains metal oxide-, carbon-, silicon-, silica-, and quantum dot-based nanocarriers. Their benefits are greater stability and well-tunable physicochemical properties, but their accumulation in the body may be a key question of their applicability. Silica nanoparticles (SNP) are silicon dioxide (SiO 2 ) nanoparticles in an amorphous state and have excellent potential in the pharmaceutical industry and drug development due to their special properties. According to pore size, the most common, most well-liked, and most effective type of silica nanocarriers are the mesoporous silica nanoparticles (MSNs) [ 1 ].

Cite this article: Silica Raw Materials News. "Silica Industry Outlook 2026: Challenges, Opportunities and Growth Areas ." Published 2026-11-20 01:33:48. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.